Skip to content

Efficacy evaluation of endometrial biopsy aiming to analyze ERA/EMMA/ALICE for patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.

Efficacy evaluation of endometrial biopsy for ERA/EMMA/ALICE analyses - Efficacy evaluation of endometrial biopsy for ERA/EMMA/ALICE analyses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053599
Enrollment
50
Registered
2024-02-13
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.

Interventions

Sponsors

Tohoku university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.

Exclusion criteria

Exclusion criteria: (1)Patient who dose not fulfill inclusion criteria (2)Patient who dose not agree with study participation (3)Patient who are receiving treatment for endometrial hyperplasia or endometrial cancer (4)Patient who have difficulty for endometrial biopsy due to congenital mullerian duct anomaly, Bleeding tendency and/or who requires hospital admission for anesthesia. (5)Patient who are pregnant or suspicious of pregnancy (6)Patient who have psychosomatic problem and have been decided to difficult to participant.

Design outcomes

Primary

MeasureTime frame
Evaluation of implantation rate when embryo transfer is performed based on ERA/EMMA/ALICE test results

Secondary

MeasureTime frame
Evaluation of clinical pregnancy rate, miscarriage rate, and live birth rate after embryo transfer based on ERA/EMMA/ALICE test results

Countries

Japan

Contacts

Public ContactEmi Yokoyama

Tohoku university graduate school of medicine Department of obstetrics

emi.yokoyama.e8@tohoku.ac.jp0227177251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026